781 related articles for article (PubMed ID: 15488676)
21. Development of pH-sensitive liposomes that efficiently retain encapsulated doxorubicin (DXR) in blood.
Ishida T; Okada Y; Kobayashi T; Kiwada H
Int J Pharm; 2006 Feb; 309(1-2):94-100. PubMed ID: 16364578
[TBL] [Abstract][Full Text] [Related]
22. Effect of cholesterol on egg yolk phosphatidylcholine peroxidation in multilamellar liposomes.
Filípek J; Uhríková D; Slosarcík P; Balgavý P
Pharmazie; 2001 Dec; 56(12):953-7. PubMed ID: 11802659
[TBL] [Abstract][Full Text] [Related]
23. New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Ghelardini C; Mura P
Int J Pharm; 2010 Aug; 395(1-2):222-31. PubMed ID: 20594944
[TBL] [Abstract][Full Text] [Related]
24. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
25. Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment.
Justo OR; Moraes AM
J Pharm Pharmacol; 2005 Jan; 57(1):23-30. PubMed ID: 15638989
[TBL] [Abstract][Full Text] [Related]
26. Pilocarpine hydrochloride liposomes: characterization in vitro and preliminary evaluation in vivo in rabbit eye.
Benita S; Plenecassagne JD; Cavé G; Drouin D; Le Hao Dong P; Sincholle D
J Microencapsul; 1984; 1(3):203-16. PubMed ID: 6336525
[TBL] [Abstract][Full Text] [Related]
27. Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method.
Nii T; Ishii F
Int J Pharm; 2005 Jul; 298(1):198-205. PubMed ID: 15951143
[TBL] [Abstract][Full Text] [Related]
28. Polymer-coated liposomes: improved liposome stability and release of cytosine arabinoside (Ara-C).
Sehgal S; Rogers JA
J Microencapsul; 1995; 12(1):37-47. PubMed ID: 7730955
[TBL] [Abstract][Full Text] [Related]
29. Phase structures of a hydrated anionic phospholipid composition containing cationic dendrimers and pegylated lipids.
Khopade AJ; Shenoy DB; Khopade SA; Jain NK
Langmuir; 2004 Aug; 20(18):7368-73. PubMed ID: 15323476
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice.
Vangala A; Kirby D; Rosenkrands I; Agger EM; Andersen P; Perrie Y
J Pharm Pharmacol; 2006 Jun; 58(6):787-99. PubMed ID: 16734980
[TBL] [Abstract][Full Text] [Related]
31. Influence of microenvironment and liposomal formulation on secondary structure and bilayer interaction of lysozyme.
Witoonsaridsilp W; Panyarachun B; Sarisuta N; Müller-Goymann CC
Colloids Surf B Biointerfaces; 2010 Feb; 75(2):501-9. PubMed ID: 19880295
[TBL] [Abstract][Full Text] [Related]
32. Intracellular distribution of fluorescent probes delivered by vesicles of different lipidic composition.
Manconi M; Isola R; Falchi AM; Sinico C; Fadda AM
Colloids Surf B Biointerfaces; 2007 Jun; 57(2):143-51. PubMed ID: 17339103
[TBL] [Abstract][Full Text] [Related]
33. Immobilization of cationic rifampicin-loaded liposomes on polystyrene for drug-delivery applications.
Pasquardini L; Lunelli L; Vanzetti L; Anderle M; Pederzolli C
Colloids Surf B Biointerfaces; 2008 Apr; 62(2):265-72. PubMed ID: 18083351
[TBL] [Abstract][Full Text] [Related]
34. 5-Fluorouracil in topical liposome gels for anticancer treatment--formulation and evaluation.
Glavas-Dodov M; Fredro-Kumbaradzi E; Goracinova K; Calis S; Simonoska M; Hincal AA
Acta Pharm; 2003 Dec; 53(4):241-50. PubMed ID: 14769231
[TBL] [Abstract][Full Text] [Related]
35. Characterization of novel multifunctional cationic polymeric liposomes formed from octadecyl quaternized carboxymethyl chitosan/cholesterol and drug encapsulation.
Liang XF; Wang HJ; Luo H; Tian H; Zhang BB; Hao LJ; Teng JI; Chang J
Langmuir; 2008 Jul; 24(14):7147-53. PubMed ID: 18564860
[TBL] [Abstract][Full Text] [Related]
36. Liposome formulations of hydrophobic drugs.
Schwendener RA; Schott H
Methods Mol Biol; 2010; 605():129-38. PubMed ID: 20072877
[TBL] [Abstract][Full Text] [Related]
37. The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs.
Ali MH; Moghaddam B; Kirby DJ; Mohammed AR; Perrie Y
Int J Pharm; 2013 Aug; 453(1):225-32. PubMed ID: 22766442
[TBL] [Abstract][Full Text] [Related]
38. Factors affecting microencapsulation of drugs in liposomes.
Kulkarni SB; Betageri GV; Singh M
J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
[TBL] [Abstract][Full Text] [Related]
39. Dexamethasone incorporating liposomes: effect of lipid composition on drug trapping efficiency and vesicle stability.
Tsotas VA; Mourtas S; Antimisiaris SG
Drug Deliv; 2007 Oct; 14(7):441-5. PubMed ID: 17994361
[TBL] [Abstract][Full Text] [Related]
40. The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations.
Anderson M; Omri A
Drug Deliv; 2004; 11(1):33-9. PubMed ID: 15168789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
